Jacobs Levy Equity Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.85M Buy
265,627
+70,042
+36% +$813K 0.02% 471
2025
Q4
$1.88M Buy
195,585
+85,771
+78% +$821K 0.01% 588
2025
Q3
$1.03M Sell
109,814
-9,524
-8% -$91K ﹤0.01% 710
2025
Q2
$1.26M Sell
119,338
-16,941
-12% -$214K 0.01% 714
2025
Q1
$2.05M Buy
136,279
+17,303
+15% +$288K 0.01% 654
2024
Q4
$1.96M Buy
+118,976
New +$2.35M 0.01% 592
2022
Q3
Sell
-16,397
Closed -$366K 991
2022
Q2
$366K Buy
+16,397
New +$366K ﹤0.01% 903
2019
Q3
Sell
-9,768
Closed -$397K 917
2019
Q2
$397K Sell
9,768
-8,980
-48% -$327K 0.01% 775
2019
Q1
$567K Buy
+18,748
New +$642K 0.01% 763
2014
Q1
Sell
-12,040
Closed -$459K 888
2013
Q4
$459K Sell
12,040
-1,200
-9% -$37K 0.01% 726
2013
Q3
$316K Buy
13,240
+500
+4% +$11.2K 0.01% 784
2013
Q2
$217K Buy
+12,740
New +$184K ﹤0.01% 879

Other funds holding ANIK